text_1: JMJD6 catalyzes the hydroxylation of C-terminal lysine and supresses transcriptional activity.
text_2: Our results reveal a novel posttranslational modification for p53 and support the pursuit of JMJD6 as a potential biomarker for colon cancer aggressiveness and a potential target for colon cancer intervention.